MGLL blocking peptide product blog
Tags: MGLL; Blocking Peptide; MGLL blocking peptide;
The MGLL mgll (Catalog #MBS9222073) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The MGLL mgll product has the following accession number(s) (GI #47117287) (NCBI Accession #Q99685.2) (Uniprot Accession #Q99685). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Converts monoacylglycerides to free fatty acids and glycerol. Hydrolyzes the endocannabinoid 2-arachidonoylglycerol, and thereby contributes to the regulation of endocannabinoid signaling, nociperception and perception of pain (By similarity). Regulates the levels of fatty acids that serve as signaling molecules and promote cancer cell migration, invasion and tumor growth.
Tissue Location: Detected in adipose tissue, lung, liver, kidney, brain and heart. Adipose Tissue, Blood, Bone, Brain, Connective Tissue, Intestine, Liver, Muscle, Placenta, Skin tissues are correlated with this protein. The following patways have been known to be associated with this gene. Breast Neoplasms, Carcinoma, Hepatocellular, Cardiovascular Diseases, Cell Transformation, Neoplastic, Disease Models, Animal, Fatty Liver, Inflammation, Liver Diseases, Weight Gain, Weight Loss are some of the diseases may be linked to MGLL Antibody (N-term) Blocking Peptide.